NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/08/2024
Back to search
Official data from USPTO
PHAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
10/08/2024
Trademark type
Word
Nice classes
5
Filing date
10/02/2020
Registration date
10/08/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/08/2024
Last transaction
10/08/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/31/2021
First use in commerce
12/31/2021
Drawing code
4
Owner type
16
Owner location
North Chicago, IL
Examiner
GOLDEN,JAMES B
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Allergan Sales, LLC
Allergan Sales, LLC
Representatives
Cheryl A. Withycombe AbbVie Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents in the form of ophthalmic solutions that facilitate the delivery of pharmaceutical preparations; Eye drops; Ophthalmic preparations
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/30/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/27/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/29/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/29/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/27/2024
GNFR
FINAL REFUSAL E-MAILED
02/27/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
02/27/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/30/2023
ALIE
ASSIGNED TO LIE
11/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/27/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/28/2022
GNRT
NON-FINAL ACTION E-MAILED
12/28/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/28/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/29/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/29/2022
IUAF
USE AMENDMENT FILED
09/16/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/15/2022
EX2G
SOU EXTENSION 2 GRANTED
03/11/2022
EXT2
SOU EXTENSION 2 FILED
03/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/16/2021
EX1G
SOU EXTENSION 1 GRANTED
09/14/2021
EXT1
SOU EXTENSION 1 FILED
09/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2020
DOCK
ASSIGNED TO EXAMINER
12/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2020
NWAP
NEW APPLICATION ENTERED
10/06/2020
Continuous trademark protection
Get notified about every new filing that threatens PHAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.